UNIGE document Scientific Article - Review
previous document  unige:153682  next document
add to browser collection
Title

Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis and dose-response meta-analysis of randomized controlled trials

Authors
Crippa, Alessio
Strauss, Gregory P
Published in International journal of neuropsychopharmacology. 2021, pyab020
Abstract Negative symptoms are a core aspect of psychopathology in schizophrenia. Currently available pharmacological agents have proven minimally efficacious for remediating negative symptoms. A promising treatment avenue is the intranasal administration of the neuropeptide oxytocin. However, there have been inconsistencies in effects of oxytocin on negative symptoms throughout the literature and factors leading to inconsistent effects are unclear.
Keywords AsocialityIntranasal oxytocinNegative symptomsOxytocinSocial deficits
Identifiers
PMID: 33890987
Full text
Article (Published version) (900 Kb) - public document Free access
Appendix (32 Kb) - public document Free access
Appendix (32 Kb) - public document Free access
Appendix (32 Kb) - public document Free access
Appendix (27 Kb) - public document Free access
Appendix (17 Kb) - public document Free access
Structures
Research group Psychopathologie clinique et expérimentale (987)
Citation
(ISO format)
SABE, Michel et al. Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis and dose-response meta-analysis of randomized controlled trials. In: International Journal of Neuropsychopharmacology, 2021, p. pyab020. doi: 10.1093/ijnp/pyab020 https://archive-ouverte.unige.ch/unige:153682

70 hits

59 downloads

Update

Deposited on : 2021-08-03

Export document
Format :
Citation style :